Caxton Associates (New York)’s Carter's CRI Stock Holding History
Bought
Maintained
Sold
Other funds holding CRI
ACH
Caxton Associates (New York)'s CRI Position: Q3 2018 in Review
Caxton Associates (New York) sold out of Carter's (CRI) in Q3 2018, closing a stake of 17,600 shares — an estimated $1.91M sold.
Caxton Associates (New York) first reported a position in CRI in Q2 2013 and held it in 5 quarters. The position peaked at $7.78M in Q2 2013. 332 funds tracked by Wall St. Rank hold CRI as of Q3 2018.
- Caxton Associates (New York) reported no remaining Carter's position as of Q3 2018 after selling out during the quarter.
- Caxton Associates (New York) sold 17,600 Carter's shares in Q3 2018, an estimated $1.91M.
- Caxton Associates (New York) first reported a position in Carter's in Q2 2013 and held it in 5 quarters.
- Caxton Associates (New York)'s Carter's position peaked at $7.78M in Q2 2013.
- 332 funds tracked by Wall St. Rank held Carter's as of Q3 2018.
Based on Caxton Associates (New York)'s 13F filing for Q3 2018, filed 14 Nov 2018.